Tower Research Capital LLC (TRC) - AVENUE THERAPEUTICS INC ownership

AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 12 filers reported holding AVENUE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,861
-26.2%
6,876
+22.2%
0.00%
Q2 2023$6,586
+73077.8%
5,629
-29.8%
0.00%
Q1 2023$9
-99.9%
8,022
+462.9%
0.00%
Q3 2022$14,0001,4250.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
EMFO, LLC 533$5,0000.01%
TWO SIGMA SECURITIES, LLC 14,159$143,0000.00%
TWO SIGMA INVESTMENTS, LP 14,342$145,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 4,538$46,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 510$5,0000.00%
MORGAN STANLEY 1,474$15,0000.00%
BlackRock Inc. 1,941$20,0000.00%
Citadel Advisors 35,865$362,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders